ACCOUNTS - Final Accounts


Caseware UK (AP4) 2021.0.152 2021.0.152 2022-03-312022-03-312trueNo description of principal activity2021-04-01false2falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10078433 2021-04-01 2022-03-31 10078433 2020-04-01 2021-03-31 10078433 2022-03-31 10078433 2021-03-31 10078433 c:Director1 2021-04-01 2022-03-31 10078433 d:CurrentFinancialInstruments 2022-03-31 10078433 d:CurrentFinancialInstruments 2021-03-31 10078433 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 10078433 d:CurrentFinancialInstruments d:WithinOneYear 2021-03-31 10078433 d:ShareCapital 2022-03-31 10078433 d:ShareCapital 2021-03-31 10078433 d:RetainedEarningsAccumulatedLosses 2022-03-31 10078433 d:RetainedEarningsAccumulatedLosses 2021-03-31 10078433 c:OrdinaryShareClass1 2021-04-01 2022-03-31 10078433 c:OrdinaryShareClass1 2022-03-31 10078433 c:OrdinaryShareClass1 2021-03-31 10078433 c:FRS102 2021-04-01 2022-03-31 10078433 c:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 10078433 c:FullAccounts 2021-04-01 2022-03-31 10078433 c:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 10078433 d:WithinOneYear 2022-03-31 10078433 d:WithinOneYear 2021-03-31 10078433 d:BetweenOneFiveYears 2022-03-31 10078433 d:BetweenOneFiveYears 2021-03-31 10078433 2 2021-04-01 2022-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 10078433










SURREY AND LONDON EYE SURGERY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2022

 
SURREY AND LONDON EYE SURGERY LIMITED
REGISTERED NUMBER: 10078433

BALANCE SHEET
AS AT 31 MARCH 2022

2022
2021
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
2,858,867
737,943

Bank and cash balances
  
839,685
1,888,842

  
3,698,552
2,626,785

Creditors: amounts falling due within one year
 5 
(666,298)
(102,168)

Net current assets
  
 
 
3,032,254
 
 
2,524,617

Total assets less current liabilities
  
3,032,254
2,524,617

  

Net assets
  
3,032,254
2,524,617


Capital and reserves
  

Called up share capital 
 6 
100
100

Profit and loss account
  
3,032,154
2,524,517

  
3,032,254
2,524,617


Page 1

 
SURREY AND LONDON EYE SURGERY LIMITED
REGISTERED NUMBER: 10078433

BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2022

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 December 2022.




Mr S M Shah
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
SURREY AND LONDON EYE SURGERY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

1.


General information

Surrey and London Eye Surgery Limited Limited is a private Company limited by shares incorporated in England and Wales within the United Kingdom. The address of the registered is 24 Old Bond Street, London, W1S 4AP. The trading address of the company is 119 Harley Street, London, W1G 6AU. This company is not part of a group. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors consider that the resources available to the company will be sufficient for it to be able to continue as a going concern. The financial statements do not contain any adjustments that would be required if the company were not able to continue as a going concern.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
SURREY AND LONDON EYE SURGERY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

2.Accounting policies (continued)

 
2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
SURREY AND LONDON EYE SURGERY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2021 - 2).

4.


Debtors

2022
2021
£
£


Trade debtors
65,995
26,136

Other debtors
2,281,145
711,807

Tax recoverable
511,727
-

2,858,867
737,943



5.


Creditors: Amounts falling due within one year

2022
2021
£
£

Corporation tax
631,423
65,717

Other taxation and social security
6,785
-

Other creditors
14,998
28,133

Accruals and deferred income
13,092
8,318

666,298
102,168


Page 5

 
SURREY AND LONDON EYE SURGERY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

6.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



100 (2021 - 100) Ordinary shares of £1.00 each
100
100



7.


Commitments under operating leases

At 31 March 2022 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2022
2021
£
£


Not later than 1 year
12,875
7,450

Later than 1 year and not later than 5 years
4,931
14,950

17,806
22,400


8.


Related party transactions

During the year the company operated loans with the directors of the company. The amount owed to the company by the directors at the year end was £1,574,544 (2021 - £17,092 owed to the directors). Interest has been charged on this loan at the HMRC approved rate of 2% as well as Section 455 tax charged at 32.5%.
During the year the company operated a loan with a company under common control. The amount owed by related party to the company at the year end was £693,500 (2021 - £693,500). This loan is interest free and repayable on demand. 


Page 6